CIK 0001653087 · Accelerated filer<br>Smaller reporting company
Alector, Inc.
Sign in to watch- Ticker
- ALEC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 822933343
- Phone
- 415-231-5660
- Business address
- 131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Alector LLC
- DEF 14A Proxy Proxy Statement
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Executive or director change
- 8-K Event Exit or restructuring costs
- 4 Open-market sale President and Head of R&D sold 29,073 shares at $1.47 ($42,662)
- 4 Open-market sale Chief Executive Officer sold 40,330 shares at $1.47 ($59,176)
- 4 Open-market sale Chief Financial Officer sold 18,091 shares at $1.47 ($26,547)
- 4 Open-market sale Chief Medical Officer sold 16,306 shares at $1.47 ($23,927)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Other events
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market sale Chief Financial Officer sold 16,489 shares at $2.52 ($41,542)
- 4 Open-market sale Chief Executive Officer sold 52,172 shares at $2.52 ($131,442)
- 4 Open-market sale President and Head of R&D sold 26,500 shares at $2.52 ($66,764)
Page 8 of 32 · 631 filings